Targeted anticancer drugs block cancer cell growth by interfering with specific signaling
pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing …

The world of rare interstitial lung diseases (ILDs) is diverse and complex. Diagnosis and
therapy usually pose challenges. This review describes a selection of rare and ultrarare …

The mechanistic target of rapamycin (mTOR) is a serine/threonine protein kinase that
regulates multiple processes, including gene transcription, protein synthesis, ribosome …

Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease caused by smooth muscle
cell-like tumors containing tuberous sclerosis (TSC) gene mutations and found almost …

Lymphangioleiomyomatosis (LAM) is a cystic lung disease of women resulting from
mutations in tuberous sclerosis complex (TSC) genes that suppress the mammalian target of …

Background: Lymphangioleiomyomatosis (LAM) is a rare disease involving multiple
systems, which is divided into sporadic LAM (S-LAM) and tuberous sclerosis complex-LAM …

Abstract Background Sporadic lymphangioleiomyomatosis (S-LAM) is a rare low-grade
neoplasm of young women characterized by multiple pulmonary cysts leading to …

Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease caused by tuberous
sclerosis complex 1/2 (TSC1/2) gene mutations in pulmonary mesenchymal cells, resulting …

Graphical abstract Abstract Lymphangioleiomyomatosis (LAM) is a cystic lung disease found
almost exclusively in genetic females and caused by small clusters of smooth muscle cell …

Background Transbronchial lung forceps biopsy (TBFB) is recommended before a surgical
lung biopsy (SLB) when a definitive diagnosis of lymphangioleiomyomatosis (LAM) is …